SEC Comment Letter for Medigus Ltd. (XYLO) (CIK 0001618500) — May 13, 2020
Medigus Ltd. (XYLO) (CIK 0001618500)
Date: May 13, 2020 · CIK: 0001618500 · Accession: 0000000000-20-004199
AI Filing Summary & Sentiment
File numbers found in text: 333-238162
Letter
United States securities and exchange commission logo May 13, 2020 Tatiana Yosef Chief Financial Officer Medigus Ltd. Omer Industrial Park, No. 7A, P.O. Box 3030 Omer 8496500, Israel Re:Medigus Ltd. Registration Statement on Form F-3 Filed May 11, 2020 File No. 333-238162 Dear Ms. Yosef: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Shachar Hadar, Adv.
Show Raw Text
United States securities and exchange commission logo
May 13, 2020
Tatiana Yosef
Chief Financial Officer
Medigus Ltd.
Omer Industrial Park, No. 7A, P.O. Box 3030
Omer 8496500, Israel
Re:Medigus Ltd.
Registration Statement on Form F-3
Filed May 11, 2020
File No. 333-238162
Dear Ms. Yosef:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Shachar Hadar, Adv.